Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Miralbell

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Archives of Internal Medicine|October 10, 2007
Short- and long-term mortality with localized prostate cancerArnaud Merglen, Franz Schmidlin, Gerald Fioretta, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failureRaymond Miralbell, Hansjörg Vees, Joan Lozano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2009
Unilateral radiotherapy for tonsil cancer: potential dose distribution optimization with a simple two-field intensity-modulated radiation therapy beam arrangementThomas Zilli, Philippe Nouet, Nathalie Casanova, et al.
The Prostate|February 11, 2011
High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: hemi-irradiation of prostate cancerUlrike Schick, Youri Popowski, Philippe Nouet, et al.
Technology in Cancer Research & Treatment|September 7, 2010
Hypofractionated extracranial stereotactic radiotherapy boost for gynecologic tumors: a promising alternative to high-dose rate brachytherapySandra Jorcano, Meritxell Molla, Lluís Escude, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2017
The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapyJulie Mareschal, Kerstin Weber, Pascale Rigoli, et al.
Zeitschrift Fur Medizinische Physik|July 2, 2021
Bilateral metallic hip implants: Are avoidance sectors necessary for pelvic VMAT treatments?Nikolaos Koutsouvelis, Giovanna Dipasquale, Michel Rouzaud, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2003
Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicityRaymond Miralbell, Daniel Taussky, Olivier Rinaldi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2003
Dosimetric implications of changes in patient repositioning and organ motion in conformal radiotherapy for prostate cancerRaymond Miralbell, Orhan Ozsoy, Angela Pugliesi, et al.
International Journal of Cancer|May 3, 2008
Recent trends in prostate cancer mortality show a continuous decrease in several countriesChristine Bouchardy, Gerald Fioretta, Elisabetta Rapiti, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Archives of Internal Medicine|October 10, 2007
Short- and long-term mortality with localized prostate cancerArnaud Merglen, Franz Schmidlin, Gerald Fioretta, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Endorectal MRI assessment of local relapse after surgery for prostate cancer: A model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failureRaymond Miralbell, Hansjörg Vees, Joan Lozano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2009
Unilateral radiotherapy for tonsil cancer: potential dose distribution optimization with a simple two-field intensity-modulated radiation therapy beam arrangementThomas Zilli, Philippe Nouet, Nathalie Casanova, et al.
The Prostate|February 11, 2011
High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: hemi-irradiation of prostate cancerUlrike Schick, Youri Popowski, Philippe Nouet, et al.
Technology in Cancer Research & Treatment|September 7, 2010
Hypofractionated extracranial stereotactic radiotherapy boost for gynecologic tumors: a promising alternative to high-dose rate brachytherapySandra Jorcano, Meritxell Molla, Lluís Escude, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2017
The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapyJulie Mareschal, Kerstin Weber, Pascale Rigoli, et al.
Zeitschrift Fur Medizinische Physik|July 2, 2021
Bilateral metallic hip implants: Are avoidance sectors necessary for pelvic VMAT treatments?Nikolaos Koutsouvelis, Giovanna Dipasquale, Michel Rouzaud, et al.
International Journal of Radiation Oncology, Biology, Physics|November 25, 2003
Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicityRaymond Miralbell, Daniel Taussky, Olivier Rinaldi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 22, 2003
Dosimetric implications of changes in patient repositioning and organ motion in conformal radiotherapy for prostate cancerRaymond Miralbell, Orhan Ozsoy, Angela Pugliesi, et al.
International Journal of Cancer|May 3, 2008
Recent trends in prostate cancer mortality show a continuous decrease in several countriesChristine Bouchardy, Gerald Fioretta, Elisabetta Rapiti, et al.
Pageof 13